 |
Ventracor’s core business is the rapid commercialisation of the VentrAssist™ LVAS.
Clinical trials to collect supporting data for CE Mark approval and permission to sell in the major market of Europe are now underway.
Please select an option from the menu below
|
© Copyright Ventracor 2002 All rights reserved Ventracor Limited ABN 46 003 180 372 |
||||||
|
||||||
| | | | | | ||||||
